» Articles » PMID: 25681002

The Effect of Light Deprivation in Patients with Stargardt Disease

Overview
Journal Am J Ophthalmol
Specialty Ophthalmology
Date 2015 Feb 15
PMID 25681002
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To investigate whether long-term protection from light exposure affects the rate of disease progression in patients with autosomal recessive Stargardt disease (STGD1), measured using fundus autofluorescence imaging.

Design: Longitudinal, retrospective, interventional case series.

Methods: Five patients with Stargardt disease protected 1 eye from light exposure by applying a black contact lens during waking hours for ≥12 months. Disease progression was followed by performing autofluorescence imaging at semi-regular intervals. Longitudinal changes in autofluorescence were studied by evaluating areas of decreased autofluorescence and areas of increased autofluorescence as a measure of retinal pigment epithelium damage and lipofuscin accumulation, respectively.

Results: We observed less progression of decreased autofluorescence in 4 out of 5 light-protected eyes relative to their respective nonprotected eyes. The progression of increased autofluorescence, on the other hand, was highly variable and did not respond consistently to treatment.

Conclusions: Areas of decreased autofluorescence may serve as a useful biomarker for measuring the progression of Stargardt disease. The reduced progression of decreased autofluorescence in the light-protected eyes suggests that light deprivation might be beneficial in patients with Stargardt disease.

Citing Articles

Abca4, mutated in Stargardt disease, is required for structural integrity of cone outer segments.

Willoughby J, Jensen A Dis Model Mech. 2024; 18(1.

PMID: 39610324 PMC: 11744051. DOI: 10.1242/dmm.052052.


Lipofuscin, Its Origin, Properties, and Contribution to Retinal Fluorescence as a Potential Biomarker of Oxidative Damage to the Retina.

Rozanowska M Antioxidants (Basel). 2023; 12(12).

PMID: 38136230 PMC: 10740933. DOI: 10.3390/antiox12122111.


Stem Cell Therapy in Stargardt Disease: A Systematic Review.

Moghadam Fard A, Mirshahi R, Naseripour M, Falavarjani K J Ophthalmic Vis Res. 2023; 18(3):318-327.

PMID: 37600916 PMC: 10432931. DOI: 10.18502/jovr.v18i3.13780.


Natural History of Stargardt Disease: The Longest Follow-Up Cohort Study.

Sajovic J, Meglic A, Fakin A, Brecelj J, Sustar Habjan M, Hawlina M Genes (Basel). 2023; 14(7).

PMID: 37510299 PMC: 10379489. DOI: 10.3390/genes14071394.


Rapamycin Inhibits Light-Induced Necrosome Activation Occurring in Wild-Type, but not RPE65-Null, Mouse Retina.

Lu C, Li S, Jin M Invest Ophthalmol Vis Sci. 2022; 63(13):19.

PMID: 36534385 PMC: 9769341. DOI: 10.1167/iovs.63.13.19.